Cytodyn Inc (CYDY)

[moneycrew]

You left out this part:
The design of many clinical trials includes some strategy for early stopping if an interim analysis reveals large differences between treatment groups, or shows obvious futility such that there is no chance that continuing to the end,
And...wait for it-

Analysis time, what about that?

So, if you take a good look at how things are panning out this past week-
Uplisting is a done deal and well as EUA being put together for a double whammy HUGE fireworks PR